ABL Bio Inc.
298380.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
25
Cost of Revenue
17
Gross Profit
25
Gross Margin
100.0%
Operating Income
-45
Operating Margin
-177.8%
Net Income
-42
Net Margin
-166.2%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-40
EBITDA Margin
-159.1%
2023
12/31/2023
Revenue
49
Cost of Revenue
0
Gross Profit
49
Gross Margin
99.9%
Operating Income
-0
Operating Margin
-0.0%
Net Income
-2
Net Margin
-4.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2
EBITDA Margin
3.2%
2022
12/31/2022
Revenue
50
Cost of Revenue
16
Gross Profit
34
Gross Margin
67.7%
Operating Income
1
Operating Margin
1.3%
Net Income
2
Net Margin
4.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
10.2%
2021
12/31/2021
Revenue
4
Cost of Revenue
20
Gross Profit
-16
Gross Margin
-397.7%
Operating Income
-38
Operating Margin
-960.1%
Net Income
-33
Net Margin
-816.9%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-31
EBITDA Margin
-775.6%
2020
12/31/2020
Revenue
6
Cost of Revenue
8
Gross Profit
-2
Gross Margin
-38.6%
Operating Income
-46
Operating Margin
-752.2%
Net Income
-42
Net Margin
-686.1%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-40
EBITDA Margin
-659.7%